Addressing Resistance to Immune Checkpoint Inhibitor Therapy: An Urgent Unmet Need
Open Access
- 21 January 2021
- journal article
- review article
- Published by Taylor & Francis in Future Oncology
- Vol. 17 (11) , 1401-1439
Abstract
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of various cancers by reversing the immunosuppressive mechanisms employed by tumors to restore anticancer immunity. Although IC...Keywords
Funding Information
- Pfizer
This publication has 367 references indexed in Scilit:
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- Coordinated regulation of myeloid cells by tumoursNature Reviews Immunology, 2012
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to ChemotherapyCancer Discovery, 2011
- Regulatory T cells and Foxp3Immunological Reviews, 2011
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's LymphomaNew England Journal of Medicine, 2010
- Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1Journal of Experimental Medicine, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- TGFβ in CancerCell, 2008
- CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cellsJournal of Clinical Investigation, 2006
- The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cellsJournal of Experimental Medicine, 2006